{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T16:29:26Z","timestamp":1792772966319,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002920","name":"University Grants Committee Research Grants Council","doi-asserted-by":"publisher","award":["T12-201\/20-R"],"award-info":[{"award-number":["T12-201\/20-R"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"University Grants Committee Research Grants Council","doi-asserted-by":"publisher","award":["12102722"],"award-info":[{"award-number":["12102722"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007162","name":"Guangdong Provincial Department of Science and Technology","doi-asserted-by":"publisher","award":["2020B1212030006"],"award-info":[{"award-number":["2020B1212030006"]}],"id":[{"id":"10.13039\/501100007162","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ijbiomac.2026.153998","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:34:11Z","timestamp":1786322051000},"page":"153998","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting transthyretin tetramer with a novel blood-brain barrier-penetrating small-molecule stabilizer for the treatment of Alzheimer's disease"],"prefix":"10.1016","volume":"380","author":[{"given":"Feng","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangying","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Ka Yam","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zonghua","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxing","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuiman","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongwei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiping","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2026.153998_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102990","article-title":"Unveiling Alzheimer\u2019s disease (1901-2025): historical insights, global burden, biological mechanisms, diagnostics, and therapeutic strategies","volume":"114","author":"Baviskar","year":"2026","journal-title":"Ageing Res. Rev."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.153998_bb0010","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019","volume":"7","author":"GBD 2019 Dementia Forecasting Collaborators","year":"2022","journal-title":"Lancet Public Health"},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.153998_bb0015","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1016\/j.immuni.2022.10.016","article-title":"Emerging roles of innate and adaptive immunity in Alzheimer's disease","volume":"55","author":"Chen","year":"2022","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153998_bb0020","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13024-025-00857-6","article-title":"Alzheimer\u2019s disease pathogenesis: standing at the crossroad of lipid metabolism and immune response","volume":"20","author":"Wang","year":"2025","journal-title":"Mol. Neurodegener."},{"issue":"52","key":"10.1016\/j.ijbiomac.2026.153998_bb0025","doi-asserted-by":"crossref","first-page":"26239","DOI":"10.1073\/pnas.1902301116","article-title":"Oligomeric A\u03b2 in the monkey brain impacts synaptic integrity and induces accelerated cortical aging","volume":"116","author":"Beckman","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.153998_bb0030","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00401-018-1922-z","article-title":"Evidence of intraneuronal A\u03b2 accumulation preceding tau pathology in the entorhinal cortex","volume":"136","author":"Welikovitch","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ijbiomac.2026.153998_bb0035","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jconrel.2024.09.012","article-title":"Amyloid-\u03b2-targeting immunotherapies for Alzheimer\u2019s disease","volume":"375","author":"Jin","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2026.153998_bb0040","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/bs.pmbts.2019.06.001","article-title":"Alzheimer\u2019s therapy development: a few points to consider","volume":"168","author":"Sigurdsson","year":"2019","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.153998_bb0045","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s40120-020-00217-0","article-title":"A narrative review of the role of transthyretin in health and disease","volume":"9","author":"Liz","year":"2020","journal-title":"Neurol Ther"},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.153998_bb0050","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/PL00000791","article-title":"Transthyretin: a review from a structural perspective","volume":"58","author":"Hamilton","year":"2001","journal-title":"Cell. Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.153998_bb0055","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1007\/s12035-024-04442-8","article-title":"Tetrameric transthyretin as a protective factor against Alzheimer\u2019s disease","volume":"62","author":"Corino","year":"2025","journal-title":"Mol. Neurobiol."},{"issue":"35","key":"10.1016\/j.ijbiomac.2026.153998_bb0060","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.2417-11.2011","article-title":"Neuronal production of transthyretin in human and murine Alzheimer\u2019s disease: is it protective?","volume":"31","author":"Li","year":"2011","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.153998_bb0065","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/cns.12707","article-title":"Transthyretin stability is critical in assisting beta amyloid clearance-relevance of transthyretin stabilization in Alzheimer\u2019s disease","volume":"23","author":"Alemi","year":"2017","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ijbiomac.2026.153998_bb0070","article-title":"Transthyretin levels and instability in Alzheimer\u2019s disease: correlations with AD biomarkers in a cohort study","author":"Gi\u00e3o","year":"2025","journal-title":"bioRxiv"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.153998_bb0075","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s40119-025-00423-7","article-title":"Transthyretin kinetic stabilizers for ATTR amyloidosis: a narrative review of mechanisms and therapeutic benefits","volume":"14","author":"Powers","year":"2025","journal-title":"Cardiol Ther"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.153998_bb0080","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nrd3675","article-title":"Tafamidis","volume":"11","author":"Said","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153998_bb0085","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.153998_bb0090","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1080\/00498254.2017.1366575","article-title":"Pharmacokinetics of tafamidis, a transthyretin amyloidosis drug, in rats","volume":"48","author":"Lee","year":"2018","journal-title":"Xenobiotica"},{"issue":"D1","key":"10.1016\/j.ijbiomac.2026.153998_bb0095","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv1072","article-title":"BindingDB in 2015: a public database for medicinal chemistry, computational chemistry and systems pharmacology","volume":"44","author":"Gilson","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.153998_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/ph17070877","article-title":"Optimization of the search for neuroprotectors among bioflavonoids","volume":"17","author":"Belenichev","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"issue":"16","key":"10.1016\/j.ijbiomac.2026.153998_bb0105","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/cmdc.201700051","article-title":"Identification of transthyretin fibril formation inhibitors using structure-based virtual screening","volume":"12","author":"Ortore","year":"2017","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ijbiomac.2026.153998_bb0110","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.chemosphere.2017.06.024","article-title":"Endocrine-disrupting activity of per- and polyfluoroalkyl substances: exploring combined approaches of ligand and structure based modeling","volume":"184","author":"Kar","year":"2017","journal-title":"Chemosphere"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.153998_bb0115","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jphs.2015.09.006","article-title":"Structural stabilization of transthyretin by a new compound, 6-benzoyl-2-hydroxy-1H-benzo [de] isoquinoline-1, 3 (2H)-dione","volume":"129","author":"Yokoyama","year":"2015","journal-title":"J. Pharmacol. Sci."},{"issue":"21","key":"10.1016\/j.ijbiomac.2026.153998_bb0120","doi-asserted-by":"crossref","first-page":"11984","DOI":"10.1021\/acs.est.6b02771","article-title":"Structure-based virtual screening protocol for in silico identification of potential thyroid disrupting chemicals targeting transthyretin","volume":"50","author":"Zhang","year":"2016","journal-title":"Environ. Sci. Technol."},{"issue":"14","key":"10.1016\/j.ijbiomac.2026.153998_bb0125","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.1021\/jm300687e","article-title":"Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking","volume":"55","author":"Mysinger","year":"2012","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.153998_bb0130","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1007\/s00044-024-03290-4","article-title":"Development of an in vitro model of the neurovascular unit for BBB permeability-linked neuroactivity screening","volume":"33","author":"Lubin","year":"2024","journal-title":"Med. Chem. Res."},{"issue":"16","key":"10.1016\/j.ijbiomac.2026.153998_bb0135","doi-asserted-by":"crossref","first-page":"6507","DOI":"10.1021\/acs.jmedchem.5b00544","article-title":"Enthalpic forces correlate with the selectivity of transthyretin-stabilizing ligands in human plasma","volume":"58","author":"Iakovleva","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2026.153998_bb0140","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.153998_bb0145","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.153998_bb0150","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","article-title":"ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB","volume":"11","author":"Maier","year":"2015","journal-title":"J. Chem. Theory Comput."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.153998_bb0155","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.153998_bb0160","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS","volume":"17","author":"Vald\u00e9s-Tresanco","year":"2021","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.ijbiomac.2026.153998_bb0165","series-title":"Gaussian 16","author":"Frisch","year":"2016"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.153998_bb0170","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/jcc.22885","article-title":"Multiwfn: a multifunctional wavefunction analyzer","volume":"33","author":"Lu","year":"2012","journal-title":"J. Comput. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153998_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"10.1016\/j.ijbiomac.2026.153998_bb0180","article-title":"Ten-fold expansion MALDI mass spectrometry imaging of tissues and cells at 500 nm resolution","author":"Xie","year":"2024","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153998_bb0185","doi-asserted-by":"crossref","DOI":"10.1186\/2045-8118-10-33","article-title":"Comparative study of four immortalized human brain capillary endothelial cell lines, hCMEC\/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood-brain barrier model for drug permeability studies","volume":"10","author":"Eigenmann","year":"2013","journal-title":"Fluids Barriers CNS."},{"issue":"24","key":"10.1016\/j.ijbiomac.2026.153998_bb0190","doi-asserted-by":"crossref","first-page":"9629","DOI":"10.1073\/pnas.1121005109","article-title":"Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade","volume":"109","author":"Bulawa","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"36","key":"10.1016\/j.ijbiomac.2026.153998_bb0195","doi-asserted-by":"crossref","first-page":"11123","DOI":"10.1021\/acs.jafc.2c00654","article-title":"Bioisosteric-replacement-driven lead optimization of tyclopyrazoflor","volume":"70","author":"Chen","year":"2022","journal-title":"J. Agric. Food Chem."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.153998_bb0200","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1021\/acs.jcim.8b00951","article-title":"Implementation of the molecular electrostatic potential over graphics processing units","volume":"59","author":"Cruz","year":"2019","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153998_bb0205","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41597-021-01054-y","article-title":"Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer\u2019s disease","volume":"8","author":"Forner","year":"2021","journal-title":"Sci. Data"},{"issue":"22","key":"10.1016\/j.ijbiomac.2026.153998_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228672","article-title":"Transthyretin stabilization: an emerging strategy for the treatment of Alzheimer\u2019s disease?","volume":"21","author":"Saponaro","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.153998_bb0215","first-page":"146","article-title":"Interaction of transthyretin with amyloid beta-protein: binding and inhibition of amyloid formation","volume":"199","author":"Schwarzman","year":"1996","journal-title":"Ciba Found. Symp."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.153998_bb0220","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3233\/JAD-131355","article-title":"Transthyretin stabilization by iododiflunisal promotes amyloid-\u03b2 peptide clearance, decreases its deposition, and ameliorates cognitive deficits in an Alzheimer\u2019s disease mouse model","volume":"39","author":"Ribeiro","year":"2014","journal-title":"J. Alzheimer\u2019s Dis"},{"key":"10.1016\/j.ijbiomac.2026.153998_bb0225","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2119\/molmed.2016.00124","article-title":"Resveratrol administration increases transthyretin protein levels ameliorating AD features- importance of transthyretin tetrameric stability","volume":"22","author":"Santos","year":"2016","journal-title":"Mol. Med."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.153998_bb0230","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/alzrt225","article-title":"Nanoparticulate flurbiprofen reduces amyloid-\u03b242 generation in an in vitro blood-brain barrier model","volume":"5","author":"Meister","year":"2013","journal-title":"Alzheimer\u2019s Res. Ther."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.153998_bb0235","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1006\/jmbi.2000.4078","article-title":"A comparative analysis of 23 structures of the amyloidogenic protein transthyretin","volume":"302","author":"H\u00f6rnberg","year":"2000","journal-title":"J. Mol. Biol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.153998_bb0240","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s40242-018-8085-2","article-title":"Molecular dynamics simulations and steered molecular dynamics simulations of Glabridin bound to wild type and V30A mutant transthyretin: ligand-linked perturbation of tertiary conformation","volume":"34","author":"YU Zhengfei","year":"2018","journal-title":"Chem. Res. Chin. Univ."},{"key":"10.1016\/j.ijbiomac.2026.153998_bb0245","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jmgm.2016.03.004","article-title":"Using DFT methodology for more reliable predictive models: design of inhibitors of Golgi \u03b1-mannosidase II","volume":"66","author":"Bobovsk\u00e1","year":"2016","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.ijbiomac.2026.153998_bb0250","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.90633","article-title":"Lost in translation: inconvenient truths on the utility of mouse models in Alzheimer\u2019s disease research","volume":"13","author":"Granzotto","year":"2024","journal-title":"Elife"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.153998_bb0255","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00401-016-1662-x","article-title":"Alzheimer\u2019s disease: experimental models and reality","volume":"133","author":"Drummond","year":"2017","journal-title":"Acta Neuropathol."},{"issue":"26","key":"10.1016\/j.ijbiomac.2026.153998_bb0260","doi-asserted-by":"crossref","first-page":"7006","DOI":"10.1523\/JNEUROSCI.1919-07.2007","article-title":"Accelerated Abeta deposition in APPswe\/PS1deltaE9 mice with hemizygous deletions of TTR (transthyretin)","volume":"27","author":"Choi","year":"2007","journal-title":"J. Neurosci."},{"issue":"38","key":"10.1016\/j.ijbiomac.2026.153998_bb0265","doi-asserted-by":"crossref","first-page":"8276","DOI":"10.1021\/bi101280t","article-title":"Characterization of the interaction of \u03b2-amyloid with transthyretin monomers and tetramers","volume":"49","author":"Du","year":"2010","journal-title":"Biochemistry"},{"issue":"29","key":"10.1016\/j.ijbiomac.2026.153998_bb0270","doi-asserted-by":"crossref","first-page":"27207","DOI":"10.1074\/jbc.M101024200","article-title":"Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants","volume":"276","author":"Quintas","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153998_bb0275","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/s41467-025-68017-4","article-title":"Amyloid-ID: photocatalytic profiling of amyloid deposits in Alzheimer\u2019s disease tissue","volume":"17","author":"Feng","year":"2026","journal-title":"Nat. Commun."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026039449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026039449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T14:03:15Z","timestamp":1792764195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026039449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":55,"alternative-id":["S0141813026039449"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.153998","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting transthyretin tetramer with a novel blood-brain barrier-penetrating small-molecule stabilizer for the treatment of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.153998","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"153998"}}